Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 3 | 2026 | 306 | 1.150 |
Why?
|
| Receptors, CCR8 | 1 | 2026 | 1 | 0.990 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2026 | 74 | 0.930 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2024 | 17 | 0.850 |
Why?
|
| Neoplasms | 2 | 2026 | 1377 | 0.780 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 140 | 0.740 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 133 | 0.730 |
Why?
|
| Interleukin-2 | 1 | 2022 | 91 | 0.700 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 88 | 0.680 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 104 | 0.670 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 495 | 0.560 |
Why?
|
| Fibronectins | 3 | 2024 | 69 | 0.380 |
Why?
|
| Immunotherapy | 2 | 2026 | 144 | 0.340 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 2676 | 0.310 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 131 | 0.250 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2024 | 8 | 0.220 |
Why?
|
| Cell Hypoxia | 2 | 2022 | 60 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2026 | 347 | 0.220 |
Why?
|
| Fibroblasts | 1 | 2024 | 281 | 0.200 |
Why?
|
| Lung | 1 | 2024 | 492 | 0.180 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 386 | 0.170 |
Why?
|
| Cobalt | 1 | 2020 | 29 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 49 | 0.160 |
Why?
|
| Cell Movement | 2 | 2021 | 655 | 0.160 |
Why?
|
| Mice | 4 | 2026 | 6644 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 80 | 0.160 |
Why?
|
| Humans | 7 | 2026 | 43102 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2017 | 30 | 0.130 |
Why?
|
| Lymphoma | 1 | 2017 | 41 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 184 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 223 | 0.110 |
Why?
|
| Animals | 4 | 2026 | 16992 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2022 | 2157 | 0.090 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 4 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 31 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 70 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 185 | 0.070 |
Why?
|
| Female | 2 | 2026 | 24698 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2021 | 181 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1596 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2021 | 411 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 38 | 0.050 |
Why?
|
| Actins | 1 | 2024 | 164 | 0.050 |
Why?
|
| Collagen | 1 | 2024 | 181 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 216 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 694 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2024 | 638 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 934 | 0.040 |
Why?
|
| Receptors, OX40 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 19 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 434 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 84 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 234 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1869 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2010 | 52 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 189 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.010 |
Why?
|